A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint

Overview of attention for article published in Frontiers in immunology, July 2021

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 57 Dimensions

Readers on

mendeley: 28 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 34,432 followers.

A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint by Xiaohan Zhou https://t.co/f4OaAN78hH

26 Jul 2021

Reply Repost Favourite

New Research: A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint: Background CD161, encoded by killer cell lectin-like receptor B1 gene, is a newly reported candidate inhibitor of tumour-infiltrating T cells. Antibody-mediated… https://t.co/

09 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.